(Q46478438)

22 December 2017

title

Antibiotic use and the risk of flare of inflammatory bowel disease (English)

1 reference

22 December 2017

inflammatory bowel diseases

main subject

antibiotic

0 references

1 reference

4

Gary R Lichtenstein

1 reference

22 December 2017

James D Lewis

5

object named as

James D Lewis

1 reference

22 December 2017

author name string

Faten N Aberra

1

1 reference

22 December 2017

Colleen M Brensinger

2

1 reference

22 December 2017

Warren B Bilker

3

1 reference

22 December 2017

language of work or name

English

0 references

publication date

1 May 2005

1 reference

22 December 2017

Clinical Gastroenterology and Hepatology

published in

1 reference

22 December 2017

volume

3

1 reference

22 December 2017

page(s)

459-465

1 reference

22 December 2017

issue

5

1 reference

22 December 2017

Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900020-0

7 January 2021

Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900020-0

7 January 2021

Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900020-0

7 January 2021

Lessons to be learned from the NOD2 gene in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900020-0

7 January 2021

Genetic variation and activity of mouse Nod2, a susceptibility gene for Crohn's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900020-0

7 January 2021

CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900020-0

7 January 2021

Are antibiotics useful in the management of nontoxic severe ulcerative colitis?

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900020-0

7 January 2021

Down-regulation of intestinal lymphocyte activation and Th1 cytokine production by antibiotic therapy in a murine model of Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900020-0

7 January 2021

The efficacy of tobramycin in the treatment of ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900020-0

7 January 2021

A controlled trial comparing ciprofloxacin with mesalazine for the treatment of active Crohn's disease. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID)

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900020-0

7 January 2021

Open label trial of oral clarithromycin in active Crohn's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900020-0

7 January 2021

Radiologic and clinical assessment of broad-spectrum antibiotic therapy in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900020-0

7 January 2021

Long-term treatment of ulcerative colitis with ciprofloxacin: a prospective, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900020-0

7 January 2021

Combined budesonide and antibiotic therapy for active Crohn's disease: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900020-0

7 January 2021

Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900020-0

7 January 2021

Seasonal variation in flares of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900020-0

7 January 2021

The VAMP Research multi-purpose database in the U.K.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900020-0

7 January 2021

Mortality in inflammatory bowel disease: a population-based cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900020-0

7 January 2021

Validity and completeness of the General Practice Research Database for studies of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900020-0

7 January 2021

Validation of information recorded on general practitioner based computerised data resource in the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900020-0

7 January 2021

Use of the UK General Practice Research Database for pharmacoepidemiology

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900020-0

7 January 2021

Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900020-0

7 January 2021

Preliminary study of ciprofloxacin in active Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900020-0

7 January 2021

Suppression of Cell-Mediated Immunity by Metronidazole

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900020-0

7 January 2021

Metronidazole inhibits leukocyte-endothelial cell adhesion in rat mesenteric venules

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900020-0

7 January 2021

Role of intestinal microflora in chronic inflammation and ulceration of the rat colon

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900020-0

7 January 2021

Multiple-dose pharmacokinetics of cefprozil and its impact on intestinal flora of volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900020-0

7 January 2021

Double blind, placebo controlled trial of metronidazole in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900020-0

7 January 2021

10.1016/S1542-3565(05)00020-0

Identifiers

DOI

1 reference

22 December 2017

PubMed ID

15880315

1 reference

22 December 2017